Charles Explorer logo
🇨🇿

Molecular characterization and clinical impact of t(11;15)(q23;q14-15) MLL-CASC5 rearrangement

Publikace na 2. lékařská fakulta |
2014

Tento text není v aktuálním jazyce dostupný. Zobrazuje se verze "en".Abstrakt

The identification of novel translocation partner genes involved in MLL rearrangements increases the chances of identifying novel possibilities for a targeted, molecular therapy. Concerted efforts by many research groups in collaboration with the Diagnostic Center of Acute Leukemia (DCAL) at Frankfurt University have made it possible to establish the MLL recombinome database.